poisar

Stocks · News reference

Ruanyun Edai Technology Inks Agreement To Grant License To BioNexus Gene Lab For Its Cogni AI Document-Intelligence Platform For Healthcare In Malaysia

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    Ruanyun Edai Technology Receives Nasdaq Noncompliance Notice

    Ruanyun Edai Technology Inc. (NASDAQ:RYET) (the "Company") today announced that it received a written notice dated October 7, 2026 from Nasdaq stating that the closing bid price of its ordinary shares was below